| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 593.696 | 556.381 | 566.453 | 497.265 | 321.118 | 354.503 | 346.867 | 365.081 | 109.063 | 6.712 |
| Total Income - EUR | 596.202 | 559.298 | 600.956 | 697.445 | 321.876 | 354.607 | 346.938 | 365.245 | 160.879 | 6.724 |
| Total Expenses - EUR | 555.819 | 496.165 | 540.566 | 448.790 | 289.136 | 315.556 | 307.769 | 326.705 | 107.604 | 6.967 |
| Gross Profit/Loss - EUR | 40.383 | 63.133 | 60.390 | 248.656 | 32.740 | 39.050 | 39.169 | 38.540 | 53.275 | -243 |
| Net Profit/Loss - EUR | 34.769 | 54.158 | 50.727 | 241.681 | 29.522 | 36.475 | 35.892 | 34.887 | 51.601 | -444 |
| Employees | 10 | 10 | 8 | 0 | 5 | 5 | 5 | 4 | 1 | 0 |
Check the financial reports for the company - Lidia Pharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 59.125 | 62.259 | 22.371 | 20.353 | 18.107 | 16.772 | 15.430 | 32.945 | 27.872 | 22.860 |
| Current Assets | 128.687 | 148.948 | 169.444 | 387.126 | 157.846 | 135.959 | 148.372 | 143.878 | 79.667 | 22.942 |
| Inventories | 61.903 | 71.279 | 58.944 | 42.446 | 35.759 | 53.233 | 50.505 | 53.803 | 2.812 | 1.730 |
| Receivables | 37.843 | 17.339 | 70.661 | 290.947 | 50.999 | 51.252 | 52.046 | 83.313 | 395 | 56 |
| Cash | 23.317 | 54.763 | 34.365 | 53.734 | 71.089 | 31.473 | 45.821 | 6.761 | 76.460 | 21.156 |
| Shareholders Funds | 85.524 | 104.395 | 100.115 | 290.162 | 77.064 | 83.116 | 81.499 | 80.636 | 106.115 | 45.170 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 102.288 | 106.811 | 91.699 | 117.317 | 98.889 | 69.614 | 82.304 | 96.187 | 1.424 | 632 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Lidia Pharm S.r.l.